Ligand Pharmaceuticals | LGND - Frais De Vente Et D'Administration

Prix De L'Action
213.44
Variation Quotidienne
8.52 4.16%
Mensuellement
2.71%
Annuel
100.24%
Q2 Prévisions
199.33




Frais De Vente Et D'Administration Changement Date
Agenus USD 10.56M 13.04M 2025-12
Amgen USD 1.94B 237M 2025-12
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Baxter International USD 761M 53M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Enviri Corporation USD 104.1M 10.81M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Glaxosmithkline GBP 3.56B 650.29M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Insmed USD 212.48M 26.11M 2025-12
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
MacroGenics USD 7.94M 1.96M 2025-12
Merck USD 2.85B 215M 2025-12
Pacira USD 91.87M 70K 2025-12
Pfizer USD 4.08B 894M 2025-12
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Veracyte USD 43.31M 8.43M 2025-12